Blueberries Medical (BBRRF) AI Stock Analysis

Top Page

Blueberries Medical

(Other OTC:BBRRF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Improved Gross MarginThe substantial improvement in gross margin indicates better economics on the revenue the company does generate. If maintained, stronger gross profitability can provide more resources to cover operating costs and improve the eventual path toward sustainable earnings.

Negative Factors

Revenue ContractionFalling trailing revenue weakens the scale needed to absorb the company’s operating cost base and makes a durable recovery more difficult. The choppy multi-year sales trend also suggests that growth has not yet become dependable enough to support predictable operating leverage.

Blueberries Medical (BBRRF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $4.47M
Dividend Yield: ―
Average Volume (3M): 117.71K
Price to Earnings (P/E): -7.1
Beta (1Y): -0.02
Revenue Growth: -36.27%
EPS Growth: 40.74%
Country: US
Employees: 51
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Blueberries Medical Business Overview & Revenue Model

Company Description

Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade cannabis and...

Blueberries Medical Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

BBRRF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:CDVA	41Neutral	CAD 2.75M	-1.04	43.99%	―	-6.27%	44.49%

* Healthcare Sector Average

Performance Comparison

BBRRF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
BBRRF	Blueberries Medical	0.01	-0.00	-9.09%
TSE:BAMM	Body & Mind	0.03	0.00	0.00%
TSE:CDVA	CordovaCann Corp	0.03	-0.00	-16.67%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Blueberries Medical AI Stock Analysis

Top Page